Literature DB >> 10047510

NMR screening in drug discovery.

J M Moore1.   

Abstract

NMR methods in drug discovery have traditionally been used to obtain structural information for drug targets or target-ligand complexes. Recently, it has been shown that NMR may be used as an alternative approach for identification of ligands that bind to protein drug targets, shifting the emphasis of many NMR laboratories towards screening and design of potential drug molecules, rather than structural characterization.

Mesh:

Substances:

Year:  1999        PMID: 10047510     DOI: 10.1016/s0958-1669(99)80010-x

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  12 in total

1.  Use of direct-infusion electrospray mass spectrometry to guide empirical development of improved conditions for expression of secondary metabolites from actinomycetes.

Authors:  J A Zahn; R E Higgs; M D Hilton
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

2.  WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability.

Authors:  C Dalvit; G Fogliatto; A Stewart; M Veronesi; B Stockman
Journal:  J Biomol NMR       Date:  2001-12       Impact factor: 2.835

3.  NMR-restrained docking of a peptidic inhibitor to the N-terminal domain of the phosphoenolpyruvate:sugar phosphotransferase enzyme I.

Authors:  D Rognan; S Mukhija; G Folkers; O Zerbe
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

Review 4.  Utilizing NMR to study the structure of growth-inhibitory proteins.

Authors:  Francesca Marassi
Journal:  Methods Mol Biol       Date:  2003

5.  Improved mapping of protein binding sites.

Authors:  Tamas Kortvelyesi; Michael Silberstein; Sheldon Dennis; Sandor Vajda
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

6.  Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Authors:  Kelly A Mercier; Robert Powers
Journal:  J Biomol NMR       Date:  2005-03       Impact factor: 2.835

Review 7.  Integration of small-molecule discovery in academic biomedical research.

Authors:  Michael Ohlmeyer; Ming-Ming Zhou
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug

8.  Oral delivery of biologically active parathyroid hormone.

Authors:  A Leone-Bay; M Sato; D Paton; A H Hunt; D Sarubbi; M Carozza; J Chou; J McDonough; R A Baughman
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

9.  Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors.

Authors:  Lei Zeng; Ken Chen; Michaela Muller; Ming-Ming Zhou
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors.

Authors:  Lei Zeng; Can Hao Chen; Michaela Muller; Ming-Ming Zhou
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.